Enliven Therapeutics ELVN Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Enliven Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enliven Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enliven Therapeutics's operating lease ROU assets?
- Enliven Therapeutics (ELVN) reported operating lease ROU assets of $290K in Q1 2026.
- How has Enliven Therapeutics's operating lease ROU assets changed year-over-year?
- Enliven Therapeutics's operating lease ROU assets decreased by 58.6% year-over-year, from $700K to $290K.
- What is the long-term trend for Enliven Therapeutics's operating lease ROU assets?
- Over 4 years (2021 to 2025), Enliven Therapeutics's operating lease ROU assets has grown at a -7.6% compound annual growth rate (CAGR), from $525K to $383K.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.